HR 6789119th CongressIn Committee
Federal Prisons Naloxone Access Act of 2025
Standard Summary
Balanced plain-English summary
This bill requires the Federal Bureau of Prisons to keep opioid overdose reversal kits available throughout federal correctional facilities, train staff and incarcerated people on their use, document each administration, protect good-faith incarcerated responders from liability, and report annually to Congress on compliance and overdoses.
Key Points
- 1Requires opioid antagonist kits in medical, housing, visiting, recreation, dining, and other prison areas.
- 2Mandates annual training for staff and incarcerated people on overdose recognition and naloxone administration.
- 3Requires recordkeeping for each overdose reversal and protects incarcerated people from liability when administering kits in good faith.
- 4Directs the Bureau of Prisons to report annually to Congress on kit supplies, overdoses, trainings, and expired kits.
- 5Authorizes $6 million for fiscal year 2026 and $2 million for each of fiscal years 2027 and 2028.
Impact Areas
incarcerated people in federal prisonsBureau of Prisons correctional officers and medical stafffederal prison health systemsCongress and federal budget oversight
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026